OncoBeta at EANM
Connect Now. Explore More During EANM.
We’ll be adding more content to this page throughout and following EANM, including presentations, videos, downloads and other congress resources. Bookmark this page and come back during or after the congress to access the latest materials. In the meantime, you can connect with our team and schedule a meeting with specific OncoBeta team members attending EANM.
Event: 39th Annual Congress of the European Association of Nuclear Medicine (EANM)
Location: Austria Center Vienna, Vienna, Austria
Date: 17-21 October 2026
Booth: 218
Meet OncoBeta at EANM 2026 and explore our scientific content, educational resources and opportunities to connect.
Who We Are
OncoBeta is a medical technology company focused on lesion-directed treatment for non-melanoma skin cancer (NMSC).
Our Rhenium-SCT® therapy uses the radioisotope rhenium-188 (Re-188) to deliver targeted treatment directly to the lesion. By combining our expertise in nuclear medicine, dermatology and medical technology, we are working to expand treatment options for patients with non-melanoma skin cancer.
Booth 218
At EANM, we are bringing together clinical insights, scientific evidence and multidisciplinary perspectives on the role of lesion-directed treatment in NMSC.
Visit us at Stand 218 to meet the OncoBeta team and discuss Rhenium-SCT® and non-melanoma skin cancer.
Meet the OncoBeta Team
Stay Connected
Stay connected with OncoBeta on LinkedIn, Facebook and Instagram for the latest updates from across our global community. We regularly share news from congresses and scientific meetings, presentations and publications, as well as educational content and general information relating to non-melanoma skin cancer and its treatment.
Contact form
Contact us
Do you have a question about OncoBeta, our products, or non-melanoma skin cancer therapy with Rhenium-SCT? Talk to us today.